MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction — Stella

Home/Preeclampsia/

View on ClinicalTrials.gov

Recruiting

Back to Preeclampsia trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Indonesia

Dr. Hasan Sadikin Central General Hospital, Bandung, West Java

Key details

Phase

Early testing / Safety & dosing

Sponsor

Universitas Padjadjaran

Collaborators

Dr. Hasan Sadikin General Hospital, Bandung, Indonesia, Dr Cipto Mangunkusumo General Hospital

Enrollment target

~80 participants

Started

July 2024

Primary completion

July 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Age range

18 Years – 50 Years

Sex

Female only

Last updated September 2025